[1] 程钊,宇传华.全球视角的中国老年人口与疾病负担现状及趋势[J].公共卫生与预防医学,2025,36(3):1-6.
[2] DU J, QIN W, WEN F, et al. Curculigoside is a Promising Osteoprotective Agent for Osteoporosis: Review. Drug Des Devel Ther. 2025;19:3323-3336.
[3] ZUPAN J, STRAZAR K, KOCIJAN R, et al. Age-related alterations and senescence of mesenchymal stromal cells: Implications for regenerative treatments of bones and joints. Mech Ageing Dev. 2021;198:111539.
[4] NERI S, BORZÌ RM. Molecular Mechanisms Contributing to Mesenchymal Stromal Cell Aging. Biomolecules. 2020;10(2):340.
[5] WENG Z, WANG Y, OUCHI T, et al. Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies. Stem Cells Transl Med. 2022;11(4):356-371.
[6] WANG B, HAN J, ELISSEEFF JH, et al. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat Rev Mol Cell Biol. 2024;25(12):958-978.
[7] PAN Y, GU Z, LYU Y, et al. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition. Rejuvenation Res. 2022;25(4):160-172.
[8] LOPES-PACIENCIA S, SAINT-GERMAIN E, ROWELL MC, et al. The senescence-associated secretory phenotype and its regulation. Cytokine. 2019;117:15-22.
[9] ZHANG D, YU K, YANG J, et al. Senolytic controls bone marrow mesenchymal stem cells fate improving bone formation. Am J Transl Res. 2020;12(6):3078-3088.
[10] CARRILLO-MARTINEZ EJ, FLORES-HERNÁNDEZ FY, SALAZAR-MONTES AM, et al. Quercetin, a Flavonoid with Great Pharmacological Capacity. Molecules. 2024;29(5):1000.
[11] YANG SY, HU Y, ZHAO R, et al. Quercetin-loaded mesoporous nano-delivery system remodels osteoimmune microenvironment to regenerate alveolar bone in periodontitis via the miR-21a-5p/PDCD4/NF-κB pathway. J Nanobiotechnology. 2024;22(1):94.
[12] FENG R, WANG Q, YU T, et al. Quercetin ameliorates bone loss in OVX rats by modulating the intestinal flora-SCFAs-inflammatory signaling axis. Int Immunopharmacol. 2024;136:112341.
[13] ZHANG F, ZHANG Y, ZHOU J, et al. Metabolic effects of quercetin on inflammatory and autoimmune responses in rheumatoid arthritis are mediated through the inhibition of JAK1/STAT3/HIF-1α signaling. Mol Med. 2024;30(1):170.
[14] LORENZO EC, TORRANCE BL, HAYNES L. Impact of senolytic treatment on immunity, aging, and disease. Front Aging. 2023;4:1161799.
[15] WANG X, ZHOU Y, LUO C, et al. Senolytics ameliorate the failure of bone regeneration through the cell senescence-related inflammatory signalling pathway. Biomed Pharmacother. 2024;175:116606.
[16] ZHOU Y, XIN X, WANG L, et al. Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice. NPJ Regen Med. 2021;6(1):34.
[17] GEORGIOU N, KAKAVA MG, ROUTSI EA, et al. Quercetin: A Potential Polydynamic Drug. Molecules. 2023;28(24):8141.
[18] BI Y, QIAO X, CAI Z, et al. Exosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cells. Cell Metab. 2025;37(2): 527-541.e6.
[19] ZHANG Y, ZHANG J, LESANI P, et al. Osteopontin Rejuvenates Senescent Adipose-Derived Stem Cells and Restores their Bone Tissue Regenerative Function. Stem Cell Rev Rep. 2024;20(4):1106-1120.
[20] LI T, MENG X, LI S, et al. Technique for Isolation and Culture of Rat Jaw Bone Marrow Mesenchymal Stem Cells. J Vis Exp. 2024;(207):e66765.
[21] ZHANG Y, YU X, ZHOU C, et al. Targeting cellular senescence in senile osteoporosis: therapeutic potential of traditional Chinese medicine. Front Med (Lausanne). 2023;10:1288993.
[22] TIAN RC, ZHANG RY, MA CF. Rejuvenation of Bone Marrow Mesenchymal Stem Cells: Mechanisms and Their Application in Senile Osteoporosis Treatment. Biomolecules. 2025;15(2):276.
[23] LI TQ, MENG XB, SHI Q, et al. Research progress in biological characteristics and influencing factors of jaw bone marrow mesenchymal stem cell. Zhonghua Kou Qiang Yi Xue Za Zhi. 2022;57(1): 107-112.
[24] 范永晶,王姝,金武龙.颌骨来源骨髓间充质干细胞成骨分化的特点、优势与应用[J].中国组织工程研究,2024,28(1):100-106.
[25] YAMAZA T, REN G, AKIYAMA K, et al. Mouse mandible contains distinctive mesenchymal stem cells. J Dent Res. 2011;90(3):317-324.
[26] LEE DJ, KWON J, CURRENT L, et al. Osteogenic potential of mesenchymal stem cells from rat mandible to regenerate critical sized calvarial defect. J Tissue Eng. 2019;10:2041731419830427.
[27] WATTS G. Leonard Hayflick and the limits of ageing. Lancet. 2011; 377(9783):2075.
[28] BRITO KNL, TRENTIN AG. Role of mesenchymal stromal cell secretome on recovery from cellular senescence: an overview. Cytotherapy. 2025; 27(4):422-437.
[29] POSPELOVA TV, LEONTIEVA OV, BYKOVA TV, et al. Suppression of replicative senescence by rapamycin in rodent embryonic cells. Cell Cycle. 2012;11(12):2402-2407.
[30] LI Y, YU P, GAO Y, et al. Effects of the combination of Epimedii Folium and Ligustri Lucidi Fructus on apoptosis and autophagy in SOP rats and osteoblasts via PI3K/AKT/mTOR pathway. Biomed Pharmacother. 2024; 173:116346.
[31] XIA TS, XU SY, LAI LY, et al. Bitter acids from Humulus lupulus L. alleviate D-galactose induced osteoblastic senescence and bone loss via regulating AKT/mTOR-mediated autophagy. J Food Drug Anal. 2024;32(4):506-519.
[32] YANCHEN F, YALI L, XUE D, et al. Exploring the multicomponent synergy mechanism of Zuogui Wan on postmenopausal osteoporosis by a systems pharmacology strategy. J Tradit Chin Med. 2024;44(3):489-495.
[33] QIU Y, ZHAO Y, JIA L, et al. Combination of dasatinib and quercetin promotes osteogenic differentiation and stemness maintenance of hPDLSCs via YAP/TAZ. Anim Cells Syst (Seoul). 2025;29(1):19-29.
[34] WANG Y, CHE L, CHEN X, et al. Repurpose dasatinib and quercetin: Targeting senescent cells ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration. Bioact Mater. 2023;25:13-28.
[35] JIA L, XIAO H, HAO Z, et al. Senolytic elimination of senescent cells improved periodontal ligament stem cell-based bone regeneration partially through inhibiting YAP. Biochim Biophys Acta Mol Cell Res. 2025;1872(3):119921.
[36] PANG XG, CONG Y, BAO NR, et al. Quercetin Stimulates Bone Marrow Mesenchymal Stem Cell Differentiation through an Estrogen Receptor-Mediated Pathway. Biomed Res Int. 2018;2018:4178021.
[37] LIN H, SOHN J, SHEN H, et al. Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing. Biomaterials. 2019;203:96-110.
[38] MARIE PJ. Bone cell senescence: mechanisms and perspectives. J Bone Miner Res. 2014;29(6):1311-1321.
[39] FARR JN, KHOSLA S. Cellular senescence in bone. Bone. 2019;121:121-133.
[40] KIM M, KIM C, CHOI YS, et al. Age-related alterations in mesenchymal stem cells related to shift in differentiation from osteogenic to adipogenic potential: implication to age-associated bone diseases and defects. Mech Ageing Dev. 2012;133(5):215-225.
[41] DING J, ZHANG R, LI H, et al. ASIC1 and ASIC3 mediate cellular senescence of human nucleus pulposus mesenchymal stem cells during intervertebral disc degeneration. Aging (Albany NY). 2021;13(7):10703-10723.
[42] HU X, LEI X, LIN W, et al. Quercetin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by modulating the miR-214-3p/Wnt3a/β-catenin signaling pathway. Exp Cell Res. 2025;444(2):114386.
[43] ZHANG W, JIA L, ZHAO B, et al. Quercetin reverses TNF α induced osteogenic damage to human periodontal ligament stem cells by suppressing the NF κB/NLRP3 inflammasome pathway. Int J Mol Med. 2021;47(4):39.
[44] YU J, JING Z, SHEN D, et al. Quercetin promotes autophagy to alleviate cigarette smoke-related periodontitis. J Periodontal Res. 2023;58(5): 1082-1095.
[45] SAXTON RA, SABATINI DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;168(6):960-976.
[46] MANNING BD, CANTLEY LC. AKT/PKB signaling: navigating downstream. Cell. 2007;129(7):1261-1274.
[47] LOPICCOLO J, BLUMENTHAL GM, BERNSTEIN WB, et al. Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations. Drug Resist Updat. 2008;11(1-2):32-50.
[48] CHU Q, LIU F, HE Y, et al. mTORC2/RICTOR exerts differential levels of metabolic control in human embryonic, mesenchymal and neural stem cells. Protein Cell. 2022;13(9):676-682.
[49] FU W, WU G. Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. Molecules. 2023;28(7):3157.
[50] MARAFIE SK, AL-MULLA F, ABUBAKER J. mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process. Int J Mol Sci. 2024;25(11):6141.
[51] WANG X, PROUD CG. The mTOR pathway in the control of protein synthesis. Physiology (Bethesda). 2006;21:362-369.
[52] TAN P, WANG YJ, LI S, et al. The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs. Mol Cell Biochem. 2016;422(1-2): 1-10.
[53] LI Y, LIU Z, YAN H, et al. Polygonatum sibiricum polysaccharide ameliorates skeletal muscle aging and mitochondrial dysfunction via PI3K/Akt/mTOR signaling pathway. Phytomedicine. 2025;136:156316.
[54] SHU Z, LI X, ZHANG W, et al. MG-132 activates sodium palmitate-induced autophagy in human vascular smooth muscle cells and inhibits senescence via the PI3K/AKT/mTOR axis. Lipids Health Dis. 2024;23(1):282.
[55] HAN W, GUAN M, LIAO B, et al. Low-intensity pulsed ultrasound inhibits chondrocyte senescence by inhibiting PI3K/AKT/mTOR signaling. Braz J Med Biol Res. 2025;58:e14408.
[56] YANG M, TENG S, MA C, et al. Ascorbic acid inhibits senescence in mesenchymal stem cells through ROS and AKT/mTOR signaling. Cytotechnology. 2018;70(5):1301-1313.
[57] MENG D, FRANK AR, JEWELL JL. mTOR signaling in stem and progenitor cells. Development. 2018;145(1):dev152595.
[58] LIU G, LI X, YANG F, et al. C-Phycocyanin Ameliorates the Senescence of Mesenchymal Stem Cells through ZDHHC5-Mediated Autophagy via PI3K/AKT/mTOR Pathway. Aging Dis. 2023;14(4):1425-1440.
[59] GUO Z, ZHANG J, LI M, et al. Mechanism of action of quercetin in regulating cellular autophagy in multiple organs of Goto-Kakizaki rats through the PI3K/Akt/mTOR pathway. Front Med (Lausanne). 2024;11:1442071.
[60] FODOR P, KIRÁLY J, SZABÓ Z, et al. Low-Dose Quercetin Dephosphorylates AKT and Suppresses Proteins Related to Migration in Human Metastatic Uveal Melanoma Cells. Life (Basel). 2025;15(6):979. |